Beyond the first episode: Candidate factors for a risk prediction model of schizophrenia

International Review of Psychiatry

Volumn 22, Issue 2, 2010, Pages 202-223

  Murphy, Brendan P ^a,b  

^a Southern Health   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ATTENTION DEFICIT DISORDER; AUTISM; COGNITIVE DEFECT; DISEASE DURATION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENETIC RISK; HEAD INJURY; INTELLECTUAL IMPAIRMENT; MENTAL HEALTH SERVICE; MIGRATION; PATERNAL AGE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PSYCHOTRAUMA; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SOCIOECONOMICS; SUBSTANCE ABUSE; URBAN AREA;

ENVIRONMENT; GENOTYPE; HUMANS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA;

EID: 77952838955     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261003661833     Document Type: Review

References (340)

1. Addington, J., Van Mastrigt, S., & Addington, D. (2003). Patterns of premorbid functioning in first-episode psychosis: Initial presentation. Schizophrenia Research, 62, 23-30.
2. Addington, J., Van Mastrigt, S., & Addington, D. (2004). Duration of untreated psychosis: Impact on 2-year outcome. Psychological Medicine, 34, 277-284.
3. Aleman, A., Kahn, R. S., & Selten, J. -P. (2003). Sex differences in the risk of schizophrenia: Evidence from meta-analysis. Archives of General Psychiatry, 60, 565-571.
4. Amminger, G. P., McGorry, P. D., Berger, G. E., Wade, D., Yung, A. R., Phillips, L. J., et al. (2007). Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biological Psychiatry, 61, 1215-1217.
5. Amminger, G. P., Schǎer, M., Papageorgiou, K., Harrigan, S., Cotton, S., McGorry, P., et al. (2008). Indicated prevention of psychotic disorders with long-chainomega-3 fatty acids: A randomized, placebo-controlled trial. Schizophrenia Research, 102, S252.
6. Amore, M., Balista, C., McCreadie, R. G., Cimmino, C., Pisani, F., Bevilacqua, G., et al. (2003). Can breast-feeding protect against schizophreniǎ Biology of the Neonate, 83, 97-101.
7. Arendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-J?gensen, P. (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: Follow-up study of 535 incident cases. British Journal of Psychiatry, 187, 510-515.
8. Arseneault, L., Cannon, M., Witton, J., & Murray, R. M. (2004). Causal association between cannabis and psychosis: Examination of the evidence. British Journal of Psychiatry, 184, 110-117. (Pubitemid 38186851)
9. Ascher-Svanum, H., Faries, D. E., Zhu, B., Ernst, F. R., Swartz, M. S., & Swanson, J. W. (2006). Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry, 67, 453-460.
10. Ashdown, H., Dumont, Y., Ng, M., Poole, S., Boksa, P., & Luheshi, G. N. (2006). The role of cytokines in mediating effects of prenatal infection in the fetus: Implications for schizophrenia. Molecular Psychiatry, 11, 47-55.
11. Atladöttir, H. O., Pedersen, M. G., Thorsen, P., Mortensen, P. B., Deleuran, B., Eaton, W. W., et al. (2009). Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics, 124, 687-694.
12. Bachmann, S., Bottmer, C., & Schroder, J. (2005). Neurological soft signs in first-episode schizophrenia: A follow-up study. American Journal of Psychiatry, 162, 2337-2343. (Pubitemid 41740213)
13. Bailer, J., Brǎer, W., & Rey, E. R. (1996). Premorbid adjustment as predictor of outcome in schizophrenia: Results of a prospective study. Acta Psychiatrica Scandinavica, 93, 368-377.
14. Barnes, T. R. E., Mutsatsa, S. H., Hutton, S. B., Watt, H. C., & Joyce, E. M. (2006). Comorbid substance abuse and age of onset of schizophrenia. British Journal of Psychiatry, 188, 237-242.
15. Barnett, J. H., Werners, U., Secher, S. M., Hill, K. E., Brazil, R., Masson, K., et al. (2007). Substance use in a population-based clinic sample of people with first-episode psychosis. British Journal of Psychiatry, 190, 515-520.
16. Bayer, T. A., Falkai, P., & Maier, W. (1999). Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the 'two-hit hypothesis'. Journal of Psychiatric Research, 33, 543-548.
17. Bennouna, M., Greene, V. B, & Defranoux, L. (2007). Cholinergic hypothesis in psychosis following traumatic brain injury and cholinergic hypothesis in schizophrenia: A link? Encephale, 33, 616-620.
18. Berger, G. E., Proffitt, T. M., McConchie, M., Yuen, H., Wood, S. J., Amminger, G. P., et al. (2007). Ethyl-eicosapentaenoic acid in first-episode psychosis: A randomized, placebo-controlled trial. Journal of Clinical Psychiatry, 68, 1867-1875.
19. Berman, S. M., Kuczenski, R., McCracken, J. T., & London, E. D. (2009). Potential adverse effects of amphetamine treatment on brain and behavior: A review. Molecular Psychiatry, 14, 123-142.
20. Bertelsen, M., Jeppesen, P., Petersen, L., Thorup, A.,lenschlaeger, J., Le Quach, P., et al. (2009). Course of illness in a sample of 265 patients with first-episode psychosis - five-year follow-up of the Danish OPUS trial. Schizophrenia Research, 107, 173-178.
21. Birchwood, M., McGorry, P., & Jackson, H. (1997). Early intervention in schizophrenia. British Journal of Psychiatry, 170, 2-5.
22. Birchwood, M., Todd, P., & Jackson, C. (1998). Early intervention in psychosis: The critical period hypothesis. British Journal of Psychiatry, 172, S33, 53-59.
23. Bodé, R., Sundströ, J., Lindströ, E., & Lindströ, L. (2009). Association between symptomatic remission and functional outcome in first-episode schizophrenia. Schizophrenia Research, 107, 232-237.
24. Boks, P. M., Russo, S., Knegtering, R., & van den Bosch, R. J. (2000). The specificity of neurological signs in schizophrenia: A review. Schizophrenia Research, 43, 109-116.
25. Boks, M. P., Selten, J. P., Leask, S., Castelein, S., & van den Bosch, R. J. (2007). Negative association between a history of obstetric complications and the number of neurological soft signs in first-episode schizophrenic disorder. Psychiatry Research, 149, 273-277.
26. Bombin, I., Arango, C., & Buchanan, R. W. (2005). Significance and meaning of neurological signs in schizophrenia: Two decades later. Schizophrenia Bulletin, 31, 962-977.
27. Bouras, N., Martin, G., Leese, M., Vanstraelen, M., Holt, G., Thomas, C., et al. (2004). Schizophrenia-spectrum psychoses in people with and without intellectual disability. Journal of Intellectual Disability Research, 48, 548-555.
28. Bow-Thomas, C. C., Velligan, D. I., Miller, A. L., & Olsen, J. (1999). Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization. Psychiatric Research, 86, 131-142.
29. Boydell, J., van Os, J., McKenzie, K., Allardyce, J., Goel, R., McCreadie, R. G., et al. (2001). Incidence of schizophrenia in ethnic minorities in London: Ecological study into interactions with the environment. British Medical Journal, 323, 1336-1338.
30. Breier, A., Buchanan, R. W., Irish, D., & Carpenter Jr, W. T. (2000). Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns. Psychiatric Services, 51, 1249-1253.
31. Breier, A. F., Malhotra, A. K., Su, T. P., Pinals, D. A., Elman, I., Adler, C. M., et al. (1999). Clozapine and risperidone in chronic schizophrenia: Effects on symptoms, Parkinsonian side effects, and neuroendocrine response. American Journal of Psychiatry, 156, 294-298.
32. Breunis, M. N., Kupka, R. W., Nolen, W. A., Suppes, T., Denicoff, K. D., Leverich, G. S., et al. (2003). High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biological Psychiatry, 53, 157-165.
33. Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., et al. (2004). Serologic evidence of prenatal influenza in the etiology of schizophrenia. Archives of General Psychiatry, 61, 774-780.
34. Brown, A. S., Bottiglieri, T., Schaefer, C. A., Quesenberry Jr, C. P., Liu, L., Bresnahan, M., et al. (2007). Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Archives of General Psychiatry, 64, 31-39.
35. Brown, A. S., Cohen, P., Greenwald, S., & Susser, E. (2000). Nonaffective psychosis after prenatal exposure to rubella. American Journal of Psychiatry, 157, 438-443.
36. Brown, A. S., Schaefer, C. A., Quesenberry Jr, C. P., Liu, L., Babulas, V. P., & Susser, E. S. (2005). Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. American Journal of Psychiatry, 162, 767-773.
37. Brown, A. S., Vinogradov, S., Kremen, W. S., Poole, J. H., Deicken, R. F., Penner, J. D., et al. (2009). Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. American Journal of Psychiatry, 66, 683-690.
38. Butzlaff, R. L., & Hooley, J. M. (1998). Expressed emotion and psychiatric relapse: A meta-analysis. Archives of General Psychiatry, 55, 547-552.
39. Bühler, B., Hambrecht, M., Löffler, W., an der Heiden, W., & Hǎner, H. (2002). Precipitation and determination of the onset and course of schizophrenia by substance abuse - a retrospective and prospective study of 232 population-based first illness episodes. Schizophrenia Research, 54, 243-251.
40. Buka, S. L., Tsuang, M. T., Torrey, E. F., Klebanoff, M.A., Bernstein, D., & Yolken, R. H. (2001). Maternal infections and subsequent psychosis among offspring. Archives of General Psychiatry, 58, 1032-1037.
41. Byrne, M., Agerbo, E., Bennedsen, B., Eaton, W. W., & Mortensen, P. B. (2007). Obstetric conditions and risk of first admission with schizophrenia: A Danish national register based study. Schizophrenia Research, 97, 51-59.
42. Byrne, M., Agerbo, E., Eaton, W. W., & Mortensen, P. B. (2004). Parental socio-economic status and risk of first admission with schizophrenia - A Danish national register based study. Social Psychiatry and Psychiatric Epidemiology, 39, 87-96.
43. Byrne, M., Agerbo, E., Ewald, H., Eaton, W. W., & Mortensen, P. B. (2003). Parental age and risk of schizophrenia: A case-control study. Archives of General Psychiatry, 60, 673-678.
44. Byrne, M., Agerbo, E., & Mortensen, P. B. (2002). Family history of psychiatric disorders and age at first contact in schizophrenia: An epidemiological study. British Journal of Psychiatry, S43, 19-25.
45. Byrne, A., Kirby, B., Zibin, T., & Ensminger, S. (1991). Psychiatric and neurological effects of chronic solvent abuse. Canadian Journal of Psychiatry, 36, 735-738.
46. Cahn, W., Rais, M., Stigter, F. P., van Haren, N. E., Caspers, E., Hulshoff Pol, H. E., et al. (2009). Psychosis and brain volume changes during the first five years of schizophrenia. European Neuropsychopharmacology, 19, 147-151.
47. Cahn, W., van Haren, N. E., Hulshoff Pol, H. E., Schnack, H. G., Caspers, E., Laponder, D. A., et al. (2006). Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. British Journal of Psychiatry, 189, 381-382.
48. Cannon, M., Jones, P. B., & Murray, R. M. (2002). Obstetrical complications and schizophrenia: Historical and meta-analytic review. American Journal of Psychiatry, 159, 1080-1092.
49. Cannon-Spoor, H. E., Potkin, S. G., & Wyatt, R. J. (1982). Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin, 8, 470-484.
50. Cantor-Grae, E., & Selten, J. P. (2005). Schizophrenia and migration: A meta-analysis and review. American Journal of Psychiatry, 162, 12-24.
51. Cantwell, R., Brewin, J., Glazebrook, C., Dalkin, T., Fox, R., Medley, I., et al. (1999). Prevalence of substance misuse in first-episode psychosis. British Journal of Psychiatry, 74, 150-153.
52. Cardno, A. G., Marshall, E. J., Coid, B., Macdonald, A. M., Ribchester, T. R., Davies, N. J., et al. (1999). Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Archives of General Psychiatry, 56, 162-168.
53. Carpenter, W. T., & Strauss, J. S. (1991). The prediction of outcome in schizophrenia: IV. Eleven-year follow-up of the Washington IPSS cohort. Journal of Nervous and Mental Disease, 179, 517-525.
54. Carroll, L. S., & Owen, M. J. (2009). Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Medicine, 1, 102.
55. Chakravarti, A. (1999). Population genetics - Making sense out of sequence. Nature Genetics, 21, S56-60.
56. Chan, R. C., Xu, T., Heinrichs, R. W., Yu., Y., & Gong, Q. Y. (2009a). Neurological soft signs in non-psychotic first-degree relatives of patients with schizophrenia: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, Epub ahead of print: PMID: 19925825.
57. Chan, R. C., Xu, T., Heinrichs, R. W., Yu, Y., & Wang, W. (2009b). Neurological soft signs in schizophrenia: A metaanalysis. Schizophrenia Bulletin, Epub ahead of print: PMID: 19377058.
58. Chen, C. K., Lin, S. K., Sham, P. C., Ball, D., Loh, E. W., Hsiao, C. C., et al. (2003). Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine, 33, 1407-1414.
59. Compton, M. T., Bollini, A. M., McKenzie Mack, L., Kryda, A. D., Rutland, J., et al. (2007a). Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls. Schizophrenia Research, 94, 64-73.
60. Compton, M. T., Carter, T., Bergner, E., Franz, L., Stewart, T., Trotman, H., et al. (2007b). Defining, operationalizing and measuring the duration of untreated psychosis: Advances, limitations and future directions. Early Intervention in Psychiatry, 1, 236-250.
61. Compton, M. T., Kelley, M. E., Ramsay, C. E., Pringle, M., Goulding, S. M., Esterberg, M. L., et al. (2009a). Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. American Journal of Psychiatry, 166, 1251-1257.
62. Compton, M. T., & Walker, E. F. (2009b). Physical manifestations of neurodevelopmental disruption: Are minor physical anomalies part of the syndrome of schizophreniǎ Schizophrenia Bulletin, 35, 425-436.
63. Conus, P., Cotton, S., Schimmelmann, B. G., McGorry, P. D., & Lambert, M. (2009). Pretreatment and outcome correlates of sexual and physical trauma in an epidemiological cohort of firstepisode psychosis patients. Schizophrenia Bulletin, Epub ahead of print: PMID: 19386579.
64. Cooper, C., Morgan, C., Byrne, M., Dazzan, P., Morgan, K., Hutchinson, G., et al. (2008). Perceptions of disadvantage, ethnicity and psychosis. British Journal of Psychiatry, 192, 185-190.
65. Corcoran, C. M., Kimhy, D., Stanford, A., Khan, S., Walsh, J., Thompson, J., et al. (2008). Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophrenia Research, 106, 286-293.
66. Craddock, N., O'Donovan, M. C., & Owen, M. J. (2005). The genetics of schizophrenia and bipolar disorder: Dissecting psychosis. Journal of Medical Genetics, 42, 193-204.
67. Craig, T. K., Garety, P., Power, P., Rahaman, N., Colbert, S., Fornells-Ambrojo, M., et al. (2004). The Lambeth Early Onset (LEO) Team: Randomised controlled trial of the effectiveness of specialised care for early psychosis. British Medical Journal, 329, 1067.
68. Crow, T. J. (2007). Genetic hypotheses for schizophrenia. British Journal of Psychiatry, 191, 180-181.
69. Crumlish, N., Whitty, P., Clarke, M., Browne, S., Kamali, M., Gervin, M., et al. (2009). Beyond the critical period: Longitudinal study of 8-year outcome in first-episode nonaffective psychosis. British Journal of Psychiatry, 194, 18-24.
70. Cullberg, J., Mattsson, M., Levander, S., Holmqvist, R., Tomsmark, L., Elingfors, C., et al. (2006). Treatment costs and clinical outcome for first episode schizophrenia patients: A 3-year follow-up of the Swedish 'Parachute Project' and two comparison groups. Acta Psychiatrica Scandinavica, 114, 274-281.
71. Dalman, C., Allebeck, P., Gunnell, D., Harrison, G., Kristensson, K., Lewis, G., et al. (2008). Infections in the CNS during childhood and the risk of subsequent psychotic illness: A cohort study of more than one million Swedish subjects. American Journal of Psychiatry, 165, 59-65.
72. Davies, G., Welham, J., Chant, D., Torrey, E. F., & McGratm, J. (2003). A systematic review and meta-analysis of northern hemisphere season of birth studies in schizophrenia, Schizophrenia. Bulletin, 29, 587-593.
73. Dazzan, P., Lloyd, T., Morgan, K. D., Zanelli, J., Morgan, C., Orr, K., et al. (2008). Neurological abnormalities and cognitive ability in first-episode psychosis. British Journal of Psychiatry, 193, 197-202.
74. Dazzan, P., & Murray, R. M. (2002). Neurological soft signs in first-episode psychosis: A systematic review. British Journal of Psychiatry, 181, 50-57, Supplement.
75. de Haan, L., Linszen, D. H., Lenior, M. E., de Win, E. D., & Gorsira, R. (2003). Duration of untreated psychosis and outcome of schizophrenia: Delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophrenia Bulletin, 29, 341-348.
76. Degenhardt, L., & Hall, W. (2006). Is cannabis use a contributory cause of psychosis? Canadian Journal of Psychiatry, 51, 556-565. (Pubitemid 44338229)
77. DeLisi, L. E. (1992). The significance of age of onset for schizophrenia. Schizophrenia Bulletin, 18, 209-215.
78. DeLisi, L. E. (2008). The concept of progressive brain change in schizophrenia: Implications for understanding schizophrenia. Schizophrenia Bulletin, 34, 312-321.
79. DeLisi, L. E., Boccio, A. M., Riordan, H., Hoff, A. L., Dorfman, A., McClelland, J., et al. (1991). Familial thyroid disease and delayed language development in first admission patients with schizophrenia. Psychiatry Research, 38, 39-50.
80. De Silva, M. J., McKenzie, K., Harpham, T., & Huttly, S. R. (2005). Social capital and mental illness: A systematic review. Journal of Epidemiology and Community Health, 59, 619-627. (Pubitemid 41081446)
81. Dickerson, F., Boronow, J., Stallings, C., Origoni, A. E., Ruslanova, I., & Yolken, R. H. (2003). Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Archives of General Psychiatry, 60, 466-472.
82. Dickerson, F. B., Ringel, N., & Parente, F. (1999). Predictors of residential independence among outpatients with schizophrenia. Psychiatric Services, 50, 515-519.
83. Dohrenwend, B. P., Levav, I., Shrout, P. E., Schwartz, S., Naveh, G., Link, B. G., et al. (1992). Socioeconomic status, psychiatric disorders and causation-selection issue. Science, 255, 946-952.
84. Done, D. J., Johnstone, E. C., Frith, C. D., Golding, J., Shepherd, P. M., & Crow, T. J. (1991). Complications of pregnancy and delivery in relation to psychosis in adult life: Data from the British perinatal mortality survey sample. British Medical Journal, 202, 1576-1580.
85. Dosseter, D. R. (2007). 'All that glitters is not gold': Misdiagnosis of psychosis in pervasive developmental disorders - A case series. Clinical Child Psychology and Psychiatry, 12, 537-548.
86. Drake, R. J., Dunn, G., Tarrier, N., Bentall, R. P., Haddock, G., & Lewis, S. W. (2007). Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. Journal of Clinical Psychiatry, 68, 81-86.
87. Drukker, M., Buka, S. L., Kaplan, C., McKenzie, K., & van Os, J. (2005). Social capital and young adolescents, perceived health in different sociocultural settings. Social Science and Medicine, 61, 185-198.
88. Drukker, M., Kaplan, C., Feron, F., & van Os, J. (2003). Children's health-related quality of life, neighbourhood socioeconomic deprivation and social capital: A contextual analysis. Social Science and Medicine, 57, 825-841.
89. Eaton, W. W., Byrne, M., Ewald, H., Mors, O., Chen, C. Y., Agerbo, E., et al. (2006). Association of schizophrenia and autoimmune diseases: Linkage of Danish national registers. American Journal of Psychiatry, 163, 521-528.
90. Eaton, W. W., Hayward, C., & Ram, R. (1992). Schizophrenia and rheumatoid arthritis: A review. Schizophrenia Research, 6, 181-192.
91. Eaton, W. W., Mortensen, P. B., Agerbo., E., Byrne, M., Mors, O., & Ewald, H. (2004). Coeliac disease and schizophrenia: Population based case control study with linkage of Danish national registers. British Medical Journal, 7437, 438-439.
92. Edwards, J., McGorry, P. D., Wadell, F. M., & Harrigan, S. M. (1999). Enduring negative symptoms in first-episode psychosis: Comparison of six methods using follow-up data. Schizophrenia Research, 40, 147-158.
93. Ehlers, S., & Gillberg, C. (1993). The epidemiology of Asperger syndrome. A total population study. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 34, 1327-1350.
94. Emsley, R., Chiliza, B., & Schoeman, R. (2008). Predictors of long-term outcome in schizophrenia. Current Opinion in Psychiatry, 21, 173-177.
95. Emsley, R., Oosthuizen, P. P., Kidd, M., Koen, L., Niehaus, D. J., & Turner, H. J. (2006). Remission in firstepisode psychosis: Predictor variables and symptom improvement patterns. Journal of Clinical Psychiatry, 67, 1707-1712.
96. Etain, B., Henry, C., Bellivier, F., Mathieu, F., & Leboyer, M. (2008). Beyond genetics: Childhood affective trauma in bipolar disorder. Bipolar Disorders, 10, 867-876.
97. Finney, G. O. (1989). Juvenile onset diabetes and schizophrenia. Lancet, 8673, 1214-1215.
98. Fisher, H. L., Craig, T. K., Fearon, P., Morgan, K., Dazzan, P., Lappin, J., et al. (2009). Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophrenia Bulletin, Epub ahead of print: PMID: 19776204.
99. Fleminger, S. (2008). Long-term psychiatric disorders after traumatic brain injury. European Journal of Anaesthesiology, S42, 123-130.
100. Flyckt, L., Mattsson, M., Edman, G., Carlsson, R., & Cullberg, J. (2006). Predicting 5-year outcome in first-episode psychosis: Construction of a prognostic rating scale. Journal of Clinical Psychiatry, 67, 916-924.
101. Frans, E. M., Sandin, S., Reichenberg, A., Lichtenstein, P., Lǎngströ, N., & Hultman, C. M. (2008). Advancing paternal age and bipolar disorder. Archives of General Psychiatry, 65, 1034-1040.
102. Ganguli, R., Rabin, B. S., Kelly, R. H., Lyte, M., & Ragu, U. (1987). Clinical and laboratory evidence of autoimmunity in acute schizophrenia. Annals of the New York Academy of Sciences, 496, 676-685.
103. Gattaz, W. F., Abrahao, A. L., & Foccacia, R. (2004). Childhood meningitis, brain maturation and the risk of psychosis. European Archives of Psychiatry and Clinical Neuroscience, 254, 23-26.
104. Geddes, J., Mercer, G., Frith, C. D., Macmillan, F., Owens, D. G. C., & Johnstone, E. C. (1994). Prediction of outcome following a first episode of schizophrenia: A follow-up study of Northwick Park first episode study subjects. British Journal of Psychiatry, 165, 664-668.
105. Gilvarry, C. M., Sham, P. C., Jones, P. B., Cannon, M., Wright, P., Lewis, S. W., et al. (1996). Family history of autoimmune diseases in psychosis. Schizophrenia Research, 19, 33-40.
106. Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., et al. (2003). Association between psychotic disorder and urban place of birth is not mediated by obstetric complications or childhood socioeconomic position: A cohort study. Psychological Medicine, 33, 723-731.
107. Goff, D. C., Cather, C., Evins, A. E., Henderson, D. C., Freudenreich, O., Copeland, P. M., et al. (2005). Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. Journal of Clinical Psychiatry, 66, 183-194.
108. Goldberg, E. M., & Morrison, S. L. (1963). Schizophrenia and social class. British Journal of Psychiatry, 109, 785-802.
109. Gourion, D., Goldberg, C., Bourdel, M. -C., Bayle., F. J., Loo, H., & Krebs, M. -O. (2004). Minor physical anomalies in patients with schizophrenia and their parents: Prevalence and pattern of craniofacial abnormalities. Psychiatry Research, 125, 21-28.
110. Gourion, D., Goldberg, C., Bourdel, M. -C., Bayle., F. J., Millet, B., Olie, J. -P., et al. (2003). Neurological soft-signs and minor physical anomalies in schizophrenia: Differential transmission within families. Schizophrenia Research, 63, 181-187.
111. Goswami, U., Sharma, A., Khastigir, U., Ferrier, I. N., Young, A. H., Gallagher, P., et al. (2006). Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. British Journal of Psychiatry, 188, 366-373.
112. Green, A. I., Tohen, M. F., Hamer, R. M., Strakowski, S. M., Lieberman, J. A., Glick, I., et al. (2004). First episode schizophrenia-related psychosis and substance use disorders: Acute response to olanzapine and haloperidol. Schizophrenia Research, 66, 125-135.
113. Hafner, H., & an der Heiden, W. (1999). The course of schizophrenia in the light of modern follow-up studies: The ABC and WHO studies. European Archives of Psychiatry and Clinical Neuroscience, 249, S4, 14-26.
114. Hafner, H., Maurer, K., Loffler, W., & Riecher-Roessler, A. (1993). The influence of age and sex on the response and early course of schizophrenia. British Journal of Psychiatry, 162, 80-86.
115. Hambrecht, M., & Hǎner, H. (2000). Cannabis, vulnerability, and the onset of schizophrenia: An epidemiological perspective. Australian and New Zealand Journal of Psychiatry, 34, 468-475.
116. Hare, E., Glahn, D. C., Dassori, A., Raventos, H., Nicolini, H., Ontiveros, A., et al. (2009). Heritability of age of onset of psychosis in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, Epub ahead of print: PMID: 19350535.
117. Harris, D., & Batki, S. L. (2000). Stimulant psychosis: Symptom profile and acute clinical course. American Journal on Addictions, 9, 28-37.
118. Harris, M. G., Henry, L. P., Harrigan, S. M., Purcell, R., Schwartz, O. S., Farrelly, S. E., et al. (2005). The relationship between duration of untreated psychosis and outcome: An eight-year prospective study. Schizophrenia Research, 79, 85-93.
119. Harrison, G., Croudace, T., Mason, P., Glazebrook, C., & Medley, I. (1996). Predicting the long-term outcome of schizophrenia. Psychological Medicine, 26, 697-705.
120. Heikkilǎ J., Karlsson, H., Taiminen, T., Lauerma, H., Ilonen, T., Leinonen, K. M., et al. (2002). Expressed emotion is not associated with disorder severity in first-episode mental disorder. Psychiatry Research, 111, 155-165.
121. Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H. -U., et al. (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal, 330, 11-14.
122. Hesdroffer, D. C., Rauch, S. L., & Tamminga, C. A. (2009). Long-term psychiatric outcomes following traumatic brain injury: A review of the literature. Journal of Head Trauma Rehabilitation, 24, 452-459.
123. Hickie, I. B., Banati, R., Stewart, C. H., & Lloyd, A. R. (2009). Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders? Medical Journal of Australia, 190, S4, 17-21.
124. Hickling, F. W., McKenzie, K., Mullen, R., & Murray, R. (1999). A Jamaican psychiatrist evaluates diagnoses at a London psychiatric hospital. British Journal of Psychiatry, 175, 283-285.
125. Hofvander, B., Delorme, R., Chaste, P., Nydé, A., Wentz, E., Stǎhlberg, O., et al. (2009). Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry, 9, 35.
126. Horrobin, D. F. (1998). The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophrenia Research, 30, 193-208.
127. Insel, B. J., Schaefer, C. A., McKeague, I. W., Susser, E. S., & Brown, A. S. (2008). Maternal iron deficiency and the risk of schizophrenia in offspring. Archives of General Psychiatry, 65, 1136-1144.
128. International Schizophrenia Consortium, Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O'Donovan, M. C., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460, 748-752.
129. Ismail, B., Cantor-Graae, E., & McNeil, T. F. (2000). Minor physical anomalies in schizophrenia: Cognitive, neurological and other clinical correlates. Journal of Psychiatric Research, 34, 45-56.
130. Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J. E., et al. (1992). Schizophrenia: Manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine, 992, 1-97.
131. Job, D. E., Whalley, H. C., McIntosh, A. M., Owens, D. G., Johnstone, E. C., & Lawrie, S. M. (2006). Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Medicine, 4, 29.
132. Jones, P., & Done, D. J. (1997). From birth to onset: A developmental perspective of schizophrenia in two national birth cohorts. In M. S. Keshaven & R. M. Murray (Eds.), Neurodevelopmental models of psychopathology (pp. 119-136). Cambridge: Cambridge University Press.
133. Jones, P., Rodgers, B., Murray, R., & Marmot, M. (1994). Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet, 344, 1398-1402.
134. Jongbloet, P. H., van Soestbergen, M., & van der Veen, E. A. (1988). Month-of-birth distribution of diabetics and ovopathy: A new aetiological view. Diabetes Research, 9, 51-58.
135. Juvonen, H., Reunanen, A., Haukka, J., Muhonen, M., Suvisaari, J., Arajǎvi, R., et al. (2007). Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus. Archives of General Psychiatry, 64, 894-899.
136. Kane, J., Marder, S. R., Schooler, N. R., Wirshing, W. C., Umbricht, D., Baker, R. W., et al. (2001). Clozapine and haloperidol in moderately refractory schizophrenia. Archives of General Psychiatry, 58, 965-972.
137. Karetkin, C., White, T., & Bingham, C. J. (2009). Shared and nonshared symptoms in youth-onset psychosis and ADHD. Journal of Attention Disorders, Epub ahead of print: PMID: 19805623.
138. Kelleher, I., Harley, M., Lynch, F., Arseneault, L., Fitzpatrick, C., & Cannon, M. (2008). Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample. British Journal of Psychiatry, 193, 378-382.
139. Kelly, B. D., O'Callaghan, E., Waddington, J. L., Feeney, L., Browne, S., Scully, P. J., et al. (2010). Schizophrenia and the city: A review of literature and prospective study of psychosis and urbanicity in Ireland. Schizophrenia Research, 116, 75-89.
140. Kendler, K. S., McGuire, M. , Gruenberg, A. M., O'Hare, A., Spellman, M., & Walsh, D. (1993). The Roscommon family study. 1. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Archives of General Psychiatry, 50, 527-540.
141. Khashan, A. S., Abel, K. M., McNamee, R., Pedersen, M. G., Webb, R. T., Baker, P. N., et al. (2008). Higher risk of offspring schizophrenia following antenatal exposure to serious adverse life events. Archives of General Psychiatry, 65, 146-152.
142. Kim, E. (2008). Does traumatic brain injury predispose individuals to develop schizophreniǎ Current Opinion in Psychiatry, 21, 286-289.
143. Kirkpatrick, B., Buchanan, R. W., Ross, D. E., & Carpenter Jr, W. T. (2001). A separate disease within the syndrome of schizophrenia. Archives of General Psychiatry, 58, 165-171.
144. Kirkpatrick, B., Herrera Castanedo, S., & Vazquez-Barquero, J. L. (2002a). Summer birth and deficit schizophrenia: Cantabria, Spain. Journal of Nervous and Mental Disease, 190, 526-532.
145. Kirkpatrick, B., Messias, E., & LaPorte, D. (2008). Schizoid-like features and season of birth in a nonpatient sample. Schizophrenia Research, 103, 151-155.
146. Kirkpatrick, B., Ram, R., Amador, X. F., Buchanan, R. W., McGlashan, T., Tohen, M., et al. (1998). Summer birth and the deficit syndrome of schizophrenia. American Journal of Psychiatry, 155, 1221-1226.
147. Kirkpatrick, B., Tek, C., Allardyce, J., Morrison, G., & McCreadie, R. (2002b). Summer birth and deficit schizophrenia in Dumfries and Galloway, southwestern Scotland. American Journal of Psychiatry, 159, 1382-1387.
148. Knight, J., Knight, A., & Ungvari, G. (1992). Can autoimmune mechanisms account for the genetic predisposition to schizophreniǎ British Journal of Psychiatry, 160, 533-540.
149. Knight, J. G., Menkes, D. B., Highton, J., & Adams, D. D. (2007). Rationale for a trial of immunosuppressive therapy in acute schziophrenia. Molecular Psychiatry, 12, 424-431.
150. Koponen, H., Rantakallio, P., Veijola, J., Jones, P., Jokelainen, J., & Isohanni, M. (2004). Childhood central nervous system infections and risk for schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 254, 9-13.
151. Krabbendam, L., & van Os, J. (2005). Schizophrenia and urbanicity: A major environmental influence - conditional on genetic risk. Schizophrenia Bulletin, 31, 795-799.
152. Kringlen, E. (2000). Twin studies in schizophrenia with special emphasis on concordance figures. American Journal of Medical Genetics, 97, 4-11.
153. Kupka, R. W., Nolen, W. A., Post, R. M., McElroy, S. L., Altshuler, L. L., Denicoff, K. D., et al. (2002). High rate of autoimmune thyroiditis in bipolar disorder: Lack of association with lithium exposure. Biological Psychiatry, 51, 305-311.
154. Lambert, T. J. (2009). The medical care of people with psychosis. Medical Journal of Australia, 190, 171-172.
155. Larsen, T. K., Moe, L. C., Vibe-Hansen, L., & Johannessen, J. O. (2000). Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophrenia Research, 45, 1-9.
156. Larsson, K., Elding-Larsson, H., Cederwall, E., Kockum, K., Neiderud, J., Sjölad, S., et al. (2004). Genetic and perinatal factors as risk for childhood type 1 diabetes. Diabetes/Metabolism Research and Reviews, 20, 429-437.
157. Lawrie, S. M., Byrne, M., Miller, P., Hodges, A., Clafferty, R. A., Cunningham Owens, D. G., et al. (2001). Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. British Journal of Psychiatry, 178, 524-530. (Pubitemid 32531745)
158. Lawrie, S. M., McIntosh, A. M., Hall, J., Owens, D. G., & Johnstone, E. C. (2008). Brain structure and function changes during the development of schizophrenia: The evidence from studies of subjects at increased genetic risk. Schizophrenia Bulletin, 34, 330-340.
159. Leask, S. J., Done, D. J., & Crow, T. J. (2002). Adult psychosis, common childhood infections and neurological soft signs in a national birth cohort. British Journal of Psychiatry, 181, 387-392.
160. Leask, S. J., Done, D. J., Crow, T. J., Richards, M., & Jones, P. B. (2000). No association between breast-feeding and adult psychosis in two national birth cohorts. British Journal of Psychiatry, 177, 218-221.
161. Lecrubier, Y., Azorin, M., Bottai, T., Dalery, J., Garreau, G., Lemperiere, T., et al. (2001). Consensus on the practical use of amisulpride, an atypical antipsychotic, in the treatment of schizophrenia. Neuropsychobiology, 44, 41-46.
162. Leeson, V. C., Barnes, T. R., Hutton, S. B., Ron, M. A., & Joyce, E. M. (2009). IQ as a predictor of functional outcome in schizophrenia: A longitudinal, four-year study of first-episode psychosis. Schizophrenia Research, 107, 55-60.
163. Leff, J., Sartorius, N., Jablensky, A., Korten, A., & Ernberg, G. (1992). The International Pilot Study of Schizophrenia: 5-year follow-up findings. Psychological Medicine, 22, 131-145.
164. Lencz, T., Smith, C. W., Auther, A., Correll, C. U., & Cornblatt, B. (2004). Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophrenia Research, 68, 37-48.
165. Lenoir, P., Bodier, C., Desombre, H., Malvy, J., Abert, B., Ould Taleb, M., et al. (2009). Prevalence of pervasive developmental disorders. A Review. Encephale, 35, 36-42.
166. Lenior, M. E., Dingemans, P. M., Schene, A. H., & Linszen, D. H. (2005). Predictors of the early 5-year course of schizophrenia: A path analysis. Schizophrenia Bulletin, 31, 781-791.
167. Lester, H., Birchwood, M., Bryan, S., England, E., Rogers, H., & Sirvastava, N. (2009). Development and implementation of early intervention services for young people with psychosis: Case study. British Journal of Psychiatry, 194, 446-450.
168. Leucht, S., Pitschel-Walz, G., Abraham, D., & Kissling, W. (1999). Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: A meta-analysis of randomized controlled trials. Schizophrenia Research, 35, 51-68.
169. Levene, J. E., Lancee, W., Seeman, M. V., Skinner, H., & Freeman, S. J. (2009). Family and patient predictors of symptomatic status in schizophrenia. Canadian Journal of Psychiatry, 54, 446-451.
170. Leweke, F. M., Gerth, C. W., Koethe, D, Klosterkötter, J., Ruslanova, I., Krivogorsky, B., et al. (2004). Antibodies to infectious agents in individuals with recent onset schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 254, 4-8.
171. Lewis, D. A., & Levitt, P. (2002). Schizophrenia as a disorder of neurodevelopment. Annual Review of Neurosciences, 25, 409-432.
172. Lewis, G., David, A., Andreasson, S., & Allebeck, P. (1992). Schizophrenia and city life. Lancet, 340, 137-140.
173. Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., et al. (2009). Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet, 373, 234-239.
174. Liddle, P. K. (1987a). Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychological Medicine, 17, 49-57.
175. Liddle, P. K. (1987b). The symptoms of chronic schizophrenia: A re-examination of the positive-negative dichotomy. British Journal of Psychiatry, 151, 145-151.
176. Liddle, P. J., & Barnes, T. R. E. (1990). Syndromes of chronic schizophrenia. British Journal of Psychiatry, 151, 145-151.
177. Lieberman, J. A. (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 80, 45-53.
178. Lieberman, J. A., Safferman, Z., Pollack, S., Szymanski, S., Johns, C., Howard, A., et al. (1994). Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome. American Journal of Psychiatry, 151, 1744-1752.
179. Lloyd, T., Dazzan, P., Dean, K., Park, S. B., Fearon, P., Doody, G. A., et al. (2008). Minor physical anomalies in patients with first-episode psychosis: Their frequency and diagnostic specificity. Psychological Medicine, 38, 71-77.
180. MacSweeney, D., Timms, P., & Johnson, A. (1978). Thryoendocrine pathology, obstetric morbidity and schizophrenia: Survey of a hundred families with a schizophrenic proband. Psychological Medicine, 8, 151-155.
181. Maki, P., Veijola, J., Jones, P. B., Murray, G. K., Koponen, H., Tienari, P., et al. (2005). Predictors of schizophrenia - a review. British Medical Bulletin, 73/74, 1-15.
182. Makikyro, T., Isohanni, M., Moring, J., Oja, H., Hakko, H., Jones, P., et al. (1997). Is a child's risk of early onset schizophrenia increased in the highest social class? Schizophrenia Research, 23, 245-252.
183. Malama, I. M., Papaioannou, D. J., Kaklamani, E. P., Katsouyanni, K. M., Koumantaki, I. G., & Trichopoulos, D. V. (1988). Birth order, sibship size and socio-economic factors in risk of schizophrenia in Greece. British Journal of Psychiatry, 152, 482-486.
184. Malaspina, D., Harlap, S., Fennig, S., Heiman, D., Nahon, D., Feldman, D., et al. (2001). Advancing paternal age and the risk of schizophrenia. Archives of General Psychiatry, 58, 361-367.
185. Malla, A., Norman, R., Bechard-Evans, L., Schmitz, N., Manchanda, R., & Cassidy, C. (2008). Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service. Psychological Medicine, 38, 1585-1593.
186. Malla, A. K., Norman, R. M., Manchanda, R., Ahmed, M. R., Scholten, D., Harricharan, R., et al. (2002). One year outcome in first episode psychosis: Influence of DUP and other predictors. Schizophrenia Research, 54, 231-242.
187. Malla, A., Norman, R., Schmitz, N., Manchanda, R., Béhard-Evans, L., Takhar, J., et al. (2006). Predictors of rate and time to remission in first-episode psychosis: A two-year outcome study. Psychological Medicine, 36, 649-658.
188. Marshall, M., Lewis, S., Lockwood, A., Drake, R., Jones, P., & Croudace, T. (2005). Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Archives of General Psychiatry, 62, 975-983.
189. Mason, P., Rimmer, M., Richman, A., Garg, G., Johnson, J., & Mottram, P. G. (2008). Middle-ear disease and schizophrenia: Case-control study. British Journal of Psychiatry, 193, 192-196.
190. Mason, P. R., & Winton, F. E. (1995). Ear disease and schizophrenia: A case control study. Acta Psychiatrica Scandinavica, 91, 217-221.
191. Mathias, S., Lubman, D., & Hides, L. (2008). Substance-induced psychosis: A diagnostic conundrum. Journal of Clinical Psychiatry, 69, 358-367.
192. McCarthy, S. E., Makarov, V., Kirov, G., Addington, A. M., McClellan., J., Yoon, S., et al. (2009). Microduplications of 16p11.2 are associated with schizophrenia. Nature Genetics, 41, 1223-1227.
193. Mattsson, M., Topor, A., Cullberg, J., & Forsell, Y. (2008). Association between financial strain, social network and fiveyear recovery from first episode psychosis. Social Psychiatry and Psychiatric Epidemiology, 43, 947-952.
194. McClellan, J., Susser, E., & King, M. -C. (2007). Schizophrenia: A common disease caused by multiple rare alleles. British Journal of Psychiatry, 190, 194-199.
195. McCreadie, R. G. (1997). The Nithsdale schizophrenia surveys. 16. Breast-feeding and schizophrenia: Preliminary results and hypotheses. British Journal of Psychiatry, 170, 334-337.
196. McGlashan, T. H. (1999). Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of coursé Biological Psychiatry, 46, 899-907.
197. McGlashan, T. H. (2006). Is active psychosis neurotoxic? Schizophrenia Bulletin, 32, 609-613.
198. McGlashan, T. H. (2008). Premorbid adjustment, onset types, and prognostic scaling: Still informativé Schizophrenia Bulletin, 34, 801-805.
199. McGorry, P. (1998). Preventive strategies in early psychosis: Verging on reality. British Journal of Psychiatry, 172, S1-2.
200. McGorry, P. D., Killackey, E., & Yung, A. R. (2007). Early intervention in psychotic disorders: Detection and treatment of the first episode and the critical early stages. Medical Journal of Australia, 187, S7, 8-10.
201. McGrath, J. J., & Welham, J. L. (1999). Season of birth and schizophrenia: A systematic review and meta-analysis of data from the Southern Hemisphere. Schizophrenia Research, 35, 237-242.
202. McGrath, J., Saha, S., Welham, J., El Saadi, O., MacCauley, C., & Chant, D. (2004). A systematic review of the incidence of schizophrenia: The distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine, 2, 13.
203. McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101, 1473-1478.
204. Mednick, S. A., Machon, R. A., Huttunen, M. O. & Bonett, D. (1988). Adult schizophrenia following exposure to an influenza epidemic. Archives of General Psychiatry, 45, 189-192.
205. Mechri, A., Gassab, L., Slama, H., Gaha, L., Saoud, M., & Krebs, M. O. (2010). Neurological soft signs and schizotypal dimensions in unaffected siblings of patients with schizophrenia. Psychiatry Research, 175, 22-26.
206. Meltzer, H. Y., Sommers, A. A., & Luchins, D. J. (1986). The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. Journal of Clinical Psychopharmacology, 6, 329-338.
207. Menezes, N. M., Malla, A. M., Norman, R. M., Archie, S., Roy, P., & Zipursky, R. B. (2009). A multi-site Canadian perspective: Examining the functional outcome from firstepisode psychosis. Acta Psychiatrica Scandinavica, 120, 138-146.
208. Menezes, P. R., Lewis, G., Rasmussen, F., Zammit, S., Sipos, A., Harrison, G. L., et al. (2009). Paternal and maternal ages at conception and risk of bipolar affective disorder in their offspring. Psychological Medicine, 23, 1-9.
209. Messias, E., & Kirkpatrick, B. (2001). Summer birth and deficit schizophrenia in the epidemiological catchment area study. Journal of Nervous and Mental Disease, 189, 608-612. (Pubitemid 32905907)
210. Messias, E., Kirkpatrick, B., Bromet, E., Ross, D., Buchanan, R. W., Carpenter Jr, W. T., et al. (2004). Summer birth and deficit schizophrenia: A pooled analysis from 6 countries. Archives of General Psychiatry, 61, 985-989.
211. Messias, E. L., Chen, C. Y., & Eaton, W. W. (2007). Epidemiology of schizophrenia: Review of findings and myths. The Psychiatric Clinics of North America, 30, 323-338.
212. Meyer, U., Yee, B. K., & Feldon, J. (2007). The neurodevelopmental impact of prenatal infections at different times in pregnancy: The earlier the worse. Neuroscientist, 13, 241-266.
213. Mihalopoulos, C., McGorry, P. D., & Carter, R. C. (1999). Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcomé Acta Psychiatrica Scandinavica, 100, 47-55.
214. Milev, P., Ho, B. -C., Arndt, S., Noupolos, P., & Andreasen, N. C. (2003). Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: A prospective longitudinal study with 5-year follow-up. Biological Psychiatry, 54, 608-615.
215. Milev, P., Ho, B. -C., Arndt, S., Noupolos, P., & Andreasen, N. C. (2005). Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: A longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry, 162, 495-506.
216. Moore, P. B., El Badri, S. M., Cousins, D., Shepherd, D. J., Young, A. H., McAllister, V. L., et al. (2001). White matter lesions and season of birth of patients with bipolar affective disorder. American Journal of Psychiatry, 158, 1521-1524.
217. Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., et al. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet, 370, 319-328.
218. Morgan, C., & Fisher, H. (2007). Environmental factors in schizophrenia: Childhood trauma - a critical review. Schizophrenia Bulletin, 33, 3-10.
219. Morgan, C., Kirkbride, J., Hutchinson, G., Craig, T., Morgan, K., Dazzan, P., et al. (2008b). Cumulative social disadvantage, ethnicity and first-episode psychosis: A casecontrol study. Psychological Medicine, 38, 1701-1715.
220. Morgan, C., Kirkbride, J., Leff, J., Craig, T., Hutchinson, G., McKenzie, K., et al. (2007). Parental separation, loss and psychosis in different ethnic groups: A case-control study. Psychological Medicine, 37, 495-503.
221. Morgan, V. A., Castle, D. J, & Jablensky, A. V. (2008a). Do women express and experience psychosis differently from men? Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders. Australian and New Zealand Journal of Psychiatry, 42, 74-82.
222. Mors, O., Mortensen, P. B., & Ewald, H. (1999). A populationbased register study of the association between schizophrenia and rheumatoid arthritis. Schizophrenia Research, 40, 67-74.
223. Mortensen, P. B., & Eaton, W. W. (2008). Diabetes mellitus and schizophrenia. Archives of General Psychiatry, 65, 237-238.
224. Mortensen, P. B., Mors, O., Frydenberg, M., & Ewald, H. (2003). Head injury as a risk factor for bipolar affective disorder. Journal of Affective Disorders, 76, 79-83.
225. Mortensen, P. B., N?gaard-Pedersen, B., Waltoft, B. L., Śiensen, T. L., Hougaard, D., Torrey, E. F., et al. (2007). Toxoplasma gondii as a risk factor for early-onset schizophrenia: Analysis of filter paper blood samples obtained at birth. Biological Psychiatry, 61, 688-693.
226. Mortensen, P. B., Pedersen, C. B., Melbye, M., Mors, O, & Ewald, H. (2003). Individual and familial risk factors for bipolar affective disorders in Denmark. Archives of General Psychiatry, 60, 1209-1215.
227. Mosholder, A. D., Gelperin, K., Hammad, T. A., Phelan, K., & Johann-Liang, R. (2009). Hallucinations and other psychotic symptoms associated with the use of attention-deficit/ hyperactivity disorder drugs in children. Pediatrics, 123, 611-616.
228. Mulvany, F., O'Callaghan, E., Takei, N., Byrne, M., Fearon, P, & Larkin, C. (2001). Effect of social class at birth on risk and presentation of schizophrenia: Case-control study. British Medical Journal, 323, 1398-1401.
229. Murphy, B. P., Chung, Y. -C., Park, T. -W., & McGorry, P. D. (2006). Pharmacological treatment of primary negative symptoms in schizophrenia: A systematic review. Schizophrenia Research, 88, 5-25.
230. Murphy, B. P., Simms, C., Dowling, R. -M., Graham, A., Doherty, A., & Meadows, G. N. (2009). On giant's shoulders: The development of the Recovery and Prevention of Psychosis Service (RAPPS) in Melbourne, Australia. Early Intervention in Psychiatry, 3, 94-99.
231. Murphy, B. P., Stuart, A. H., & McGorry, P. D. (2008). Duration of untreated negative symptoms and duration of active negative symptoms: Proof of concepts. Early Intervention in Psychiatry, 2, 27-33.
232. Murray, R. M., & van Os, J. (1998). Predictors of outcome in schizophrenia. Journal of Clinical Psychopharmacology, 18, S2-4.
233. Nettelbladt, P., Göth, M., Bogren, M., & Mattisson, C. (2009). Risk of mental disorders in subjects with intellectual disability in the Lundby cohort 1947-97. Nordic Journal of Psychiatry, 63, 316-321.
234. Norman, R. M. G., & Malla, A. K. (2001). Duration of untreated psychosis: A critical examination of the concept and its importance. Psychological Medicine, 31, 381-400.
235. Nylander, L. (2008). Autism spectrum disorders and schizophrenia spectrum disorders - Is there a connection? A literature review and some suggestions for future clinical research. Clinical Neuropsychiatry, 5, 43-54.
236. Norman, R. M., Malla, A. K., Manchanda, R., Harricharan, R., Takhar, J., & Northcott, S. (2005). Social support and threeyear symptom and admission outcomes for first episode psychosis. Schizophrenia Research, 80, 227-234.
237. Odegaard, O. (1932). Emigration and insanity. Acta Psychiatrica et Neurologica Scandinavica, S4, 1-206.
238. O'Donovan, M. C., Kirov, G., & Owen, M. J. (2008). Phenotypic variations on the theme of CNVs. Nature Genetics, 40, 1392-1393.
239. O'Dwyer, J. M. (1997). Schizophrenia in people with intellectual disability: The role of pregnancy and birth complications. Journal of Intellectual Disability Research, 41, 238-251.
240. Oken, R. J., & Schulzer, M. (1999). At issue: Schizophrenia and rheumatoid arthritis: The negative association revisited. Schizophrenia Bulletin, 25, 625-638.
241. Padmos, R. C., Bekris, L., Knijff, E. M., Tiemeier, H., Kupka, R. W., Cohen, D., et al. (2004). A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biological Psychiatry, 56, 476-482.
242. Pantelis, C., Yücel, M., Wood, S. J., Velakoulis, D., Sun, D., Berger, G., et al. (2005). Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia Bulletin, 31, 672-696.
243. Pedersen, C. B., & Mortensen, P. B. (2001). Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Archives of General Psychiatry, 58, 1039-1046.
244. Pedersen, C. B., Raaschou-Nielsen, O., Hertel, O., & Mortensen, P. B. (2004). Air pollution from traffic and schizophrenia risk. Schizophrenia Research, 66, 83-85.
245. Peet, M. (2003). Eicosapentaenoic acid in the treatment of schizophrenia and depression: Rationale and preliminary double-blind clinical trial results. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 69, 477-485.
246. Peet, M., & Stokes, C. (2005). Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs, 65, 1051-1059.
247. Peet, M., Poole, J., & Laugharne, J. (1997). Infant feeding and the development of schizophrenia. Schizophrenia Research, 24, 255-256.
248. Penner, J. D., & Brown, A. S. (2007). Prenatal infectious and nutritional factors and risk of adult schizophrenia. Expert Review of Neurotherapeutics, 7, 797-805.
249. Perkins, D. O., Gu, H., Boteva, K., & Lieberman, J. A. (2005). Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. American Journal of Psychiatry, 162, 1785-1804.
250. Perrin, M. C., Opler, M. G., Harlap, S., Harkavy-Friedman, J., Kleinhaus, K., Nahon, D., et al. (2007). Tetrachloroethylene exposure and risk of schizophrenia: Offspring of dry cleaners in a population birth cohort, preliminary findings. Schizophrenia Research, 90, 251-254.
251. Perkins, D., Lieberman, J., Gu, H., Tohen, M., McEvoy, J., Green, A., et al. (2004). HGDH Research Group. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. British Journal of Psychiatry, 185, 18-24.
252. Petersen, L., Jeppesen, P., Thorup, A., Abel, M. B., lenschlaeger, J., Christensen, T. , et al. (2005). A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. British Medical Journal, 331, 602-605.
253. Petersen, L., Thorup, A., hlenschlaeger, J., Christensen, T. , Jeppesen, P., Krarup, G., et al. (2008). Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial. Canadian Journal of Psychiatry, 53, 660-670.
254. Prasad, K. M., Sahni, S. D., Rohm, B. R., & Keshavan, M. S. (2005). Dorsolateral prefrontal cortex morphology and shortterm outcome in first-episode schizophrenia. Psychiatry Research, 140, 147-155.
255. Rabinowitz, J., Levine, S. Z., & Hǎner, H. (2006). A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophrenia Research, 88, 96-101.
256. Ramirez, N., Arranz, B., Salavert, J., Alvarez, E., Corripio, I., Dueñas, R. M., et al. (2010). Predictors of schizophrenia in patients with a first episode of psychosis. Psychiatry Research, 175, 11-14.
257. Read, J., van Os, J., Morrison, A. P., & Ross, C. A. (2005). Childhood trauma, psychosis, and schizophrenia: A literature review with theoretical and clinical implications. Acta Psychiatrica. Scandinavica., 112, 330-350.
258. Reichenberg, A. (2005). Cognitive impairment as a risk factor for psychosis. Dialogues in Clinical Neuroscience, 7, 31-38.
259. Reichenberg, A., Weiser, M., Rapp, M. A., Rabinowitz, J., Caspi, A., Schmeidler, J., et al. (2006). Premorbid intraindividual variability in intellectual performance and risk for schizophrenia: A population-based study. Schizophrenia Research, 85, 49-57.
260. Robinson, D., Woerner, M. G., Alvir, J. M., Bilder, R., Goldman, R., Geisler, S., et al. (1999). Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 56, 241-247. (Pubitemid 29125132)
261. Roehr, B. (2005). Half a million Americans use methamphetamine every week. British Medical Journal, 331, 476.
262. Rosen, K., & Garety, P. (2005). Predicting recovery from schizophrenia: A retrospective comparison of characteristics at onset of people with single and multiple episodes. Schizophrenia Bulletin, 31, 735-750.
263. Rothermundt, M., Arolt, V., & Bayer, T. A. (2001). Review of immunological and immunopathological findings in schizophrenia. Brain, Behaviour, and Immunity, 15, 319-339.
264. Roy, M. A., Maziade, M., Labbé A., & Méette, C. (2001). Male gender is associated with deficit schizophrenia: A metaanalysis. Schizophrenia Research, 47, 141-147.
265. Ruiz-Veguilla, M., Gurpegui, M., Barrigö, M. L., Ferr, M., Mar, E., Rubio, J. L., et al. (2009). Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use. Schizophrenia Research, 107, 158-164.
266. Saha, S., Chant, D. C., Welham, J. L., & McGrath, J. J. (2006a). The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatrica Scandinavica, 114, 36-39.
267. Saha, S., Welham, J., Chant, D., & McGrath, J. (2006b). Incidence of schizophrenia does not vary with economic status of the country: Evidence from a systematic review. Social Psychiatry and Psychiatric Epidemiology, 41, 338-340.
268. Sasaki, T., Okazaki, Y., Akaho, R., Masui, K., Harada, S., Lee, I., et al. (2000). Type of feeding during infancy and later development of schizophrenia. Schizophrenia Research, 42, 79-82.
269. Schimmelmann, B. G., Huber, C. G., Lambert, M., Cotton, S., McGorry, P. D., & Conus, P. (2008). Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. Journal of Psychiatric Research, 42, 982-990.
270. Schreier, A., Wolke, D., Thomas, K., Horwood, J., Hollis, C., Gunnell, D., et al. (2009). Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12 years. Archives of General Psychiatry, 66, 527-536.
271. Sewell, R. A., Ranganathan, M., & D'Souza, D. C. (2009). Cannabinoids and psychosis. International Review of Psychiatry, 21, 152-162.
272. Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001). A review of MRI findings in schizophrenia. Schizophrenia Research, 49, 1-52.
273. Shepherd, M., Watt, D., Falloon, I., & Smeeton, N. (1989). The natural history of schizophrenia: A five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychological Medicine, 15, 1-46, Monograph suppl.
274. Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe'er, I., et al. (2009). Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature, 460, 753-757.
275. Simonsen, E., Friis, S., Haahr, U., Johannessen, J. O., Larsen, T. K., Melle, I., et al. (2007). Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors. Acta Psychiatrica Scandinavica, 116, 54-61.
276. Singh, S. P. (2007). Outcome measures in early psychosis; relevance of duration of untreated psychosis. British Journal of Psychiatry, S50, 58-63.
277. Śiensen, H. J., Mortensen, E. L., Reinisch, J. M., & Mednick, S. A. (2003). Do hypertension and diuretic treatment in pregnancy increase the risk of schizophrenia in offspring? American Journal of Psychiatry, 160, 464-468.
278. Śiensen, H. J., Mortensen, E. L., Reinisch, J. M., & Mednick, S. A. (2005). Breastfeeding and risk of schizophrenia in the Copenhagen Perinatal Cohort. Acta Psychiatrica Scandinavica, 112, 26-29.
279. Śiensen, H. J., Mortensen, E. L., Reinisch, J. M., & Mednick, S. A. (2009). Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophrenia Bulletin, 35, 631-637.
280. Spauwen, J., Krabbendam, L., Lieb, R., Wittchen, H. U., & van Os, J. (2004). Early maternal stress and health behaviours and offspring expression of psychosis in adolescence. Acta Psychiatrica Scandinavica, 110, 356-364.
281. St Clair, D., Xu, M., Wang, P., Yu, Y., Fang, Y., Zhang, F., et al. (2005). Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. Journal of the American Medical Association, 294, 557-562.
282. Steen, R. G., Mull, C., McClure, R., Hamer, R. M., & Lieberman, J. A. (2006). Brain volume in first-episode schizophrenia: Systematic review and meta-analysis of magnetic resonance imaging studies. British Journal of Psychiatry, 188, 510-518.
283. Stefanis, N. C., Delespaul, P., Smyrnis, N., Lembesi, A., Avramopoulos, D. A., Evdokimidis, I. K., et al. (2004). Is the excess risk of psychosis-like experiences in urban areas attributable to altered cognitive development? Social Psychiatry and Psychiatric Epidemiology, 39, 364-368.
284. Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., et al. (2009). Common variants conferring risk of schizophrenia. Nature, 460, 744-747.
285. Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003). Schizophrenia as a complex trait: Evidence from a metaanalysis of twin studies. Archives of General Psychiatry, 60, 1187-1192.
286. Susser, E., Neugebauer, R., Hoek, H. W., Brown, A. S., Lin, S., Labovitz, D., et al. (1996). Schizophrenia after prenatal famine. Further evidence. Archives of General Psychiatry, 53, 25-31.
287. Suvisaari, J., Haukka, J., Tanskanen, A., Hovi, T., & Lönqvist, J. (1999). Association between prenatal exposure to poliovirus infection and adult schizophrenia. American Journal of Psychiatry, 156, 1100-1102.
288. Suvisaari, J., Mautemps, N., Haukka, J., Hovi, T., & Lönqvist, J. (2003). Childhood central nervous system viral infections and adult schizophrenia. American Journal of Psychiatry, 160, 1183-1185.
289. Tamminga, C. A., Buchanan, R. W., & Gold, J. M. (1998). The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. International Clinical Psychopharmacology, 13, S3, 21-26.
290. Tandon, R., Keshavan, M. S., & Nasrallah, H. (2008a). Schizophrenia, 'just the facts': What we know in 2008 part 1: Overview. Schizophrenia Research, 100, 4-19.
291. Tandon, R., Keshavan, M. S., & Nasrallah, H. (2008b). Schizophrenia, 'just the facts': What we know in 2008 part 2. Epidemiology and etiology. Schizophrenia Research, 102, 1-18.
292. Tek, C., Kirkpatrick, B., Kelly, C., & McCreadie, R. G. (2001). Summer birth and deficit schizophrenia in Nithsdale, Scotland. Journal of Nervous and Mental Disease, 189, 613-617.
293. Thorup, A., Petersen, L., Jeppesen, P., & Nordentoft, M. (2007c). Frequency and predictive values of first rank symptoms at baseline among 362 young adult patients with first-episode schizophrenia results from the Danish OPUS study. Schizophrenia Research, 97, 60-67.
294. Thorup, A., Petersen, L., Jeppesen, P., Ohlenschlaeger, J., Christensen, T., Krarup, G., et al. (2007b). Gender differences in young adults with first-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study. Journal of Nervous and Mental Disease, 195, 396-405.
295. Thorup, A., Waltoft, B. L., Pedersen, C. B., Mortensen, P. B., & Nordentoft, M. (2007a). Young males have a higher risk of developing schizophrenia: A Danish register study. Psychological Medicine, 37, 479-484.
296. Tienari, P., Wynne, L. C., Lǎsy, K., Moring, J., Nieminen, P., Sorri, A., et al. (2003). Genetic boundaries of the schizophrenia spectrum: Evidence from the Finnish Adoptive Family Study of Schizophrenia. American Journal of Psychiatry, 160, 1587-1594.
297. Tienari, P., Wynne, L. C., Sorri, A., Lahti, I., Lǎsy, K., Moring, J., et al. (2004). Genotype-environment interaction in schizophrenia-spectrum disorder. Long-term follow-up study of Finnish adoptees. British Journal of Psychiatry, 184, 216-222.
298. Tiffin, P., & Glover, G. (2007). From commitment to reality: Early intervention in psychosis services in England. Early Intervention in Psychiatry, 1, 104-107.
299. Torrey, E. F., Bartko, J. J., Lun, Z. R., & Yolken, R. H. (2007). Antibodies to Toxoplasma gondii in patients with schizophrenia: A meta-analysis. Schizophrenia Bulletin, 33, 729-736.
300. Torrey, E. F., Buka, S., Cannon, T. D., Goldstein, J. M., Seidman, L. J., Liu, T., et al. (2009). Paternal age as a risk factor for schizophrenia: How important is it? Schizophrenia Research, 114, 1-5.
301. Torrey, E. F., Miller, J., Rawlings, R., & Yolken, R. H. (1997). Seasonality of birth in schizophrenia and bipolar disorder: A review of the literature. Schizophrenia Research, 28, 1-38.
302. Torrey, E. F., Rawlings, R. R., Ennis, J. M., Merrill, D. D., & Flores, D. S. (1996). Birth seasonality in bipolar disorder, schizophrenia, schizoaffective disorder, and stillbirths. Schizophrenia Research, 21, 141-149.
303. van Haren, N. E., Chan, W., Hulshoff Pol, H. E., Schnack, H. G., Caspers, E., Lemstra, A., et al. (2003). Brain volumes as predictor of outcome in recent-onset schizophrenia: A multi-center MRI study. Schizophrenia Research, 64, 41-52.
304. van Lieshout, R. J., & Voruganti, L. P. (2008). Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: A review of the evidence and putative mechanisms. Journal of Psychiatry & Neuroscience, 33, 395-404.
305. van Os, J. (2004). Does the urban environment cause psychosis? British Journal of Psychiatry, 184, 287-288.
306. van Os, J., Bak, M., Hanssen, M., Bijl, R. V., de Graaf, R., & Verdoux, H. (2002). Cannabis use and psychosis: A longitudinal population-based study. American Journal of Epidemiology, 156, 319-327.
307. van Winkel, R., Myin-Germeys, I., De Hert, M., Delespaul, P., Peuskens, J., & van Os, J. (2007). The association between cognition and functional outcome in first-episode patients with schizophrenia: Mystery resolved? Acta Psychiatrica Scandinavica, 116, 119-124.
308. van Winkel, R., Myin-Germeys, I., Delespaul, P., Peuskens, J., De Hert, M., & van Os, J. (2006). Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: A 10-year follow-up study. Schizophrenia Research, 88, 47-54.
309. Veling, W., Hoek, H. W., & Mackenbach, J. P. (2008a). Perceived discrimination and the risk of schizophrenia in ethnic minorities: A case-control study. Social Psychiatry and Psychiatric Epidemiology, 43, 953-959.
310. Veling, W., Selten, J. P., Susser, E., Laan, W., Mackenbach, J. P., & Hoek, H. W. (2007). Discrimination and the incidence of psychotic disorders among ethnic minorities in the Netherlands. International Journal of Epidemiology, 36, 761-768.
311. Veling, W., Susser, E., van Os, J., Mackenbach, J. P., Selten, J. P., & Hoek, H. W. (2008b). Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants. American Journal of Psychiatry, 165, 66-73.
312. Volkow, N. D. (2009). Substance use disorders in schizophrenia - clinical implications of comorbidity. Schizophrenia Bulletin, 35, 469-472.
313. Vonk, R., van der Schot, A. C., Kahn, R. S., Nolen, W. A., & Drexhage, H. A. (2007). Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? Biological Psychiatry, 62, 135-140.
314. Waddington, J. L. (2007). Neuroimaging and other neurobiological indices in schizophrenia: Relationship to measurement of functional outcome. British Journal of Psychiatry, S50, 52-57.
315. Wade, D., Harrigan, S., Edwards, J., Burgess, P. M., Whelan, G., & McGorry, P. D. (2005). Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis. Australian and New Zealand Journal of Psychiatry, 39, 892-898. (Pubitemid 43904454)
316. Wade, D., Harrigan, S., Edwards, J., Burgess, P. M., Whelan, G., & McGorry, P. D. (2006a). Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophrenia Research, 81, 145-150.
317. Wade, D., Harrigan, S., Edwards, J., Burgess, P. M., Whelan, G., & McGorry, P. D. (2006b). Substance misuse in first-episode psychosis: 15-month prospective follow-up study. British Journal of Psychiatry, 189, 229-234. (Pubitemid 44343467)
318. Welham, J., Chant, D., Saha, S., McGrath, J., Kirkpatrick, B., & Castle, D. (2006). No association between the deficit syndrome in psychosis and summer birth in a Southern hemisphere country. Australian and New Zealand Journal of Psychiatry, 40, 935-936.
319. Welham, J., Isohanni, M., Jones, P., & McGrath, J. (2009). The antecedents of schizophrenia: A review of birth cohort studies. Schizophrenia Bulletin, 35, 603-623.
320. White, C., Stirling, J., Hopkins, R., Morris, J., Montague, L., Tantam, D., et al. (2009). Predictors of 10-year outcome of first-episode psychosis. Psychological Medicine, 39, 1447-1456.
321. Whitty, P., Clarke, M., McTigue, O., Browne, S., Gervin, M., Kamali, M., et al. (2006). Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophrenia Research, 86, 110-117.
322. Wiersma, D., Giel, R., De Jong, A., & Slooff, C. J. (1983). Social class and schizophrenia in a Dutch cohort. Psychological Medicine, 13, 141-150.
323. Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R. (1998). Natural course of schizophrenic disorders: A 15-year followup of a Dutch incidence cohort. Schizophrenia Bulletin, 24, 75-85.
324. Wieselgren, I. M., & Lindstrom, L. H. (1996). A prospective 1-5 year outcome study in first-admitted and readmitted schizophrenic patients; Relationship to heredity, premorbid adjustment, duration of disease and education level at index admission and neuroleptic treatment. Acta Psychiatrica Scandinavica, 93, 9-19.
325. Wilcox, J. A., & Nasrallah, H. A. (1987). Childhood head trauma and psychosis. Psychiatry Research, 21, 303-306.
326. Wohl, M., & Gorwood, P. (2007). Paternal ages below or above 35 years old are associated with a different risk of schizophrenia in the offspring. European Psychiatry, 22, 22-26.
327. Wood, S. J., Pantelis, C., Yung, A. R., Velakoulis, D., & McGorry, P. D. (2009). Brain changes during the onset of schizophrenia: Implications for neurodevelopmental theories. Medical Journal of Australia, 190, S4, 10-13.
328. Woodberry, K. A., Giuliano, A. J., & Seidman, L. J. (2008). Premorbid IQ in schizophrenia: A meta-analytic review. American Journal of Psychiatry, 165, 579-587.
329. Wright, P., Donaldson, P. T., Underhill, J. A., Choudhuri, K., Doherty, D. G., & Murray, R. M. (1996b). Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. American Journal of Psychiatry, 153, 1530-1533.
330. Wright, P., Sham, P. C., Gilvarry, C. M., Jones, P. B., Cannon, M., Sharma, T., et al. (1996a). Autoimmune diseases in the pedigrees of schizophrenic and control subjects. Schizophrenia Research, 20, 261-267.
331. Wyatt, R. J. (1991). Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin, 17, 325-351.
332. Xu, M. Q., Sun, W. S., Liu, B. X., Feng, G. Y., Yu, L., Yang, L., et al. (2009). Prenatal malnutrition and adult schizophrenia: Further evidence from the 1959-1961 Chinese famine. Schizophrenia Bulletin, 35, 568-576.
333. Yolken, R. H., & Torrey, E. F. (2008). Are some cases of psychosis caused by microbial agents? A review of the evidence. Molecular Psychiatry, 5, 470-479.
334. Yuii, K., Suzuki, M., & Kurachi, M. (2007). Stress sensitization in schizophrenia. Annals of the New York Academy of Sciences, 1113, 276-290.
335. Yun, Y., Phillips, L. J., Cotton, S., Yung, A. R., Francey, S. M., Yuen, H. P., et al. (2005). Obstetric complications and transition to psychosis in an 'ultra' high risk sample. Australian and New Zealand Journal of Psychiatry, 39, 460-466.
336. Yung, A. R., & McGorry, P. D. (1996). The prodromal phase of first episode psychosis: Past and current conceptualisations. Schizophrenia Bulletin, 22, 353-370.
337. Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. British Medical Journal, 325, 1199.
338. Zammit, S., Allebeck, P., David, A. S., Dalman, C., Hemmingsson, T., Lundberg, I., et al. (2004). A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Archives of General Psychiatry, 61, 354-360.
339. Zammit, S., Thomas, K., Thompson, A., Horwood, J., Menezes, P., Gunnell, D., et al. (2009). Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring. British Journal of Psychiatry, 195, 294-300.
340. Zhang, Q., & Sachdev, P. S. (2003). Psychotic disorder and traumatic brain injury. Current Psychiatry Reports, 5, 197-201.